[go: up one dir, main page]

EA200800502A1 - Соединения 3-аминокарбазола, фармацевтическая композиция, содержащая указанные соединения, и способ их получения - Google Patents

Соединения 3-аминокарбазола, фармацевтическая композиция, содержащая указанные соединения, и способ их получения

Info

Publication number
EA200800502A1
EA200800502A1 EA200800502A EA200800502A EA200800502A1 EA 200800502 A1 EA200800502 A1 EA 200800502A1 EA 200800502 A EA200800502 A EA 200800502A EA 200800502 A EA200800502 A EA 200800502A EA 200800502 A1 EA200800502 A1 EA 200800502A1
Authority
EA
Eurasian Patent Office
Prior art keywords
compounds
pharmaceutical composition
production
composition containing
aminocarbazole
Prior art date
Application number
EA200800502A
Other languages
English (en)
Other versions
EA012786B1 (ru
Inventor
Мария Алессандра Ализи
Патриция Драгоне
Гвидо Фурлотти
Никола Каццолла
Винченцо Руссо
Джорджина Мангано
Изабелла Колетта
Лоренцо Поленцани
Original Assignee
Ацьенде Кимике Рьюните Анджелини Франческо A.K.P.A.Ф. С.П.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ацьенде Кимике Рьюните Анджелини Франческо A.K.P.A.Ф. С.П.А. filed Critical Ацьенде Кимике Рьюните Анджелини Франческо A.K.P.A.Ф. С.П.А.
Publication of EA200800502A1 publication Critical patent/EA200800502A1/ru
Publication of EA012786B1 publication Critical patent/EA012786B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Соединение формулы (I), где R1, R2, R3, R4, R5, R6, Х и Y имеют значения, указанные в описании, и его фармацевтически приемлемые соли. Фармацевтическая композиция, содержащая соединение формулы (I) или его фармацевтически приемлемую соль. Способ получения вышеупомянутого соединения формулы (I) и его фармацевтически приемлемых солей.
EA200800502A 2005-08-03 2006-07-25 Соединения 3-аминокарбазола, фармацевтическая композиция, содержащая указанные соединения, и способ их получения EA012786B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT001523A ITMI20051523A1 (it) 2005-08-03 2005-08-03 Composto del 3-ammino-carbazolo composizione farmaceutica che lo contiene e metodo per prepararlo
PCT/EP2006/007393 WO2007014687A1 (en) 2005-08-03 2006-07-25 3-aminocarbazole compounds, pharmaceutical composition containing the same and method for the preparation thereof

Publications (2)

Publication Number Publication Date
EA200800502A1 true EA200800502A1 (ru) 2008-06-30
EA012786B1 EA012786B1 (ru) 2009-12-30

Family

ID=35501077

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200800502A EA012786B1 (ru) 2005-08-03 2006-07-25 Соединения 3-аминокарбазола, фармацевтическая композиция, содержащая указанные соединения, и способ их получения

Country Status (23)

Country Link
US (2) US7879900B2 (ru)
EP (1) EP1910288B1 (ru)
JP (1) JP5274252B2 (ru)
KR (1) KR101278620B1 (ru)
CN (1) CN101223139B (ru)
AR (1) AR056014A1 (ru)
AT (1) ATE471930T1 (ru)
AU (1) AU2006275063B2 (ru)
BR (1) BRPI0615158A8 (ru)
CA (1) CA2609441C (ru)
DE (1) DE602006015062D1 (ru)
DK (1) DK1910288T3 (ru)
EA (1) EA012786B1 (ru)
ES (1) ES2345944T3 (ru)
GE (1) GEP20104964B (ru)
IL (1) IL187713A (ru)
IT (1) ITMI20051523A1 (ru)
MX (1) MX2008001551A (ru)
PL (1) PL1910288T3 (ru)
PT (1) PT1910288E (ru)
SI (1) SI1910288T1 (ru)
UA (1) UA93378C2 (ru)
WO (1) WO2007014687A1 (ru)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2119705A1 (en) * 2008-05-14 2009-11-18 AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.p.A. 3-Aminocarbozole compound, pharmaceutical composition containing it and preparation method therefor
GB0812185D0 (en) 2008-07-03 2008-08-13 Dow Corning Polymers modified by silanes
GB0812186D0 (en) 2008-07-03 2008-08-13 Dow Corning Modified polyolefins
WO2010019271A1 (en) * 2008-08-15 2010-02-18 Georgetown University Fluorescent regulators of rassf1a expression and human cancer cell proliferation
GB201000117D0 (en) 2010-01-06 2010-02-17 Dow Corning Organopolysiloxanes containing an unsaturated group
GB201000128D0 (en) 2010-01-06 2010-02-24 Dow Corning Modified polymers
GB201000121D0 (en) 2010-01-06 2010-02-17 Dow Corning Modified polyolefins
GB201000120D0 (en) 2010-01-06 2010-02-17 Dow Corning Process for forming crosslinked and branched polymers
GB201006846D0 (en) 2010-04-23 2010-06-09 Glaxo Group Ltd Novel compounds
MX2010014124A (es) * 2010-12-17 2012-06-18 Gabriel Diaz Hernandez Solución antiséptica local de amplio espectro a base de hipodorito de sodio, bicarbonato de sodio, cloramfenicol, jabón y solución salina al 0.9%.
FR2972193B1 (fr) 2011-03-04 2014-07-04 Setup Performance Polyolefines modifiees, reticulables apres transformation, et procede de fabrication desdites polyolefines
US10376672B2 (en) 2013-03-15 2019-08-13 Auris Health, Inc. Catheter insertion system and method of fabrication
US11053255B2 (en) 2015-06-22 2021-07-06 Georgetown University Synthesis of mahanine and related compounds
JP2023520367A (ja) * 2020-03-25 2023-05-17 エスアールアイ インターナショナル リポキシゲナーゼ阻害剤
CN112159345B (zh) * 2020-11-18 2023-08-25 湖北和昌新材料科技股份有限公司 N-乙基咔唑的合成方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4940719A (en) 1986-03-27 1990-07-10 Merck Frosst Canada, Inc. Tetrahydrocarbazole esters, pharmaceutical compositions and use
JP2002241368A (ja) * 1997-02-18 2002-08-28 Shionogi & Co Ltd 新規ベンゾラクタム誘導体およびそれを含有する医薬組成物
US6399631B1 (en) 1999-07-23 2002-06-04 Pfizer Inc. Carbazole neuropeptide Y5 antagonists
AU6000900A (en) 1999-07-23 2001-02-13 Astrazeneca Uk Limited Carbazole derivatives and their use as neuropeptide y5 receptor ligands
AU769081B2 (en) * 1999-08-26 2004-01-15 Bristol-Myers Squibb Company NPY antagonists: spiroisoquinolinone derivatives
BR0116388A (pt) 2000-12-22 2003-09-30 Astrazeneca Ab Composto, processo para preparar um composto, composição farmacêutica e método para tratar, em um animal de sangue quente, distúrbios de alimentação e uso de um composto
DE10125961A1 (de) 2001-05-29 2002-12-12 Boehringer Ingelheim Int Carbazolderivate und deren Verwendung zur Herstellung einer Arzneimittelzusammensetzung zur Behandlung von im Zusammenhang mit NPY stehenden Leiden
CA2403307A1 (en) * 2001-10-23 2003-04-23 Neurogen Corporation Substituted 2-cyclohexyl-4-phenyl-1h-imidazole derivatives
ES2193875B2 (es) * 2002-04-09 2005-03-01 Laboratorios Del Dr. Esteve, S.A. Derivados de benzoxazinona, su preparacion y su aplicacion como medicamentos.
ITMI20050909A1 (it) 2005-05-19 2006-11-20 Acraf Uso di un benzoil derivato dal 3-ammino-carbazolo per la produzione di un farmaco per il trattamento di un disturbo associato alla produzione di prostaglandina e2-pge2-

Also Published As

Publication number Publication date
UA93378C2 (ru) 2011-02-10
CA2609441A1 (en) 2007-02-08
IL187713A (en) 2011-09-27
IL187713A0 (en) 2008-08-07
US8207214B2 (en) 2012-06-26
US20080207727A1 (en) 2008-08-28
EP1910288A1 (en) 2008-04-16
DK1910288T3 (da) 2010-10-11
PL1910288T3 (pl) 2010-11-30
BRPI0615158A8 (pt) 2018-03-06
AR056014A1 (es) 2007-09-12
CN101223139B (zh) 2010-11-17
MX2008001551A (es) 2008-04-22
PT1910288E (pt) 2010-08-18
SI1910288T1 (sl) 2010-10-29
EP1910288B1 (en) 2010-06-23
ATE471930T1 (de) 2010-07-15
EA012786B1 (ru) 2009-12-30
ES2345944T3 (es) 2010-10-06
GEP20104964B (en) 2010-04-26
ITMI20051523A1 (it) 2007-02-04
AU2006275063A1 (en) 2007-02-08
AU2006275063B2 (en) 2012-03-08
JP5274252B2 (ja) 2013-08-28
KR20080040691A (ko) 2008-05-08
US20110046197A1 (en) 2011-02-24
CN101223139A (zh) 2008-07-16
CA2609441C (en) 2013-09-03
BRPI0615158A2 (pt) 2011-05-03
JP2009502999A (ja) 2009-01-29
WO2007014687A1 (en) 2007-02-08
DE602006015062D1 (de) 2010-08-05
HK1112916A1 (en) 2008-09-19
US7879900B2 (en) 2011-02-01
KR101278620B1 (ko) 2013-06-25

Similar Documents

Publication Publication Date Title
CY1116885T1 (el) Υποκατεστημενα παραγωγα κυκλοεξυλομεθυλιου
MX2009004900A (es) Arilamidas sustituidas por tiazol u oxazol.
EA200800502A1 (ru) Соединения 3-аминокарбазола, фармацевтическая композиция, содержащая указанные соединения, и способ их получения
NO20060665L (no) N-substituerte pyrazolyl-amidyl-benzimidazolyl C-kit inhibitorer
EA200700096A1 (ru) Производные 2-карбамид-4-фенилтиазола, способ их получения и их применение в терапии
TW200628154A (en) Organic compounds
TW200640900A (en) 1-(2h)-isoquinolone derivative
TNSN04250A1 (en) Diphenyl azetidinones substituted by acidic groups, method for their production, medicaments containing said compounds and use thereof.
IL183373A0 (en) 3-[2-(3-acylamino-2-oxo-2h-pyridin-1-yl)-acetylamino]-4-oxo-pentanoic acid derivatives, pharmaceutical compositions containing the same and methods for the preparation thereof
DE602004008959D1 (de) Benzoäbüä1,4üdioxepinderivate
HRP20041202A2 (en) Cationically substituted diphenyl azetidinones, method for their production, medicaments containing said compounds and use thereof
EA200500690A1 (ru) Новые соединения пиридопиримидинона, способ их получения и фармацевтические композиции, которые их содержат
BRPI0519292A2 (pt) compostos orgÂnicos
TW200639156A (en) New compounds
SE0403085D0 (sv) Novel componds
TW200714598A (en) Urea derivatives, methods for their manufacture, and uses therefor
EA200870223A1 (ru) Производные бензоизоиндола для лечения боли
EA200300272A1 (ru) Новые производные хиназолина, способ их получения и фармацевтические композиции, содержащие их
ATE528301T1 (de) Verfahren zur herstellung von substituierten sulfoxidzusammensetzungen
EA200600760A1 (ru) Новые соединения фенилпиридилпиперазина, способ их получения и фармацевтические композиции, содержащие их
CR8955A (es) Hexadecasacaridos biotinilados, su preparacion y su utilizacion
EA200401082A1 (ru) Новые соединения бензоиндолина, способ их получения и фармацевтические композиции, которые их содержат
EA200970496A1 (ru) Соединения 2-алкилиндазола для лечения некоторых расстройств цнс
TW200510401A (en) Process for the preparation of insulin sensitizer
MX2007004400A (es) Procedimiento para la preparacion de n-(3,5-dicloropirid-a-il)-4- ifluorometoxi-8-metanosulfonamido-dibenzo [b,d] difuran-1-carboxamida.

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): RU